HB 1095 Maryland House of Delegates · 2020 Regular Session

Public Health - Prescription Drug Affordability Board and Fund

Bill status signed all 5 stages cleared

Introduction

Feb 2020

Committee Review

Mar 2020

House of Delegates Passage

Mar 2020

Senate Passage

Mar 2020

Signed into Law

Feb 2021

Introduced Feb 6, 2020 Signed Feb 12, 2021

Floor votes · House of Delegates Mar 12, 2020

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 12, 2021

Vetoed

Motion Special Order vote on veto until later today (Senator King) Adopted

upper

Feb 8, 2021

Vetoed

Motion Special Order vote on veto until 2/11 (Delegate Luedtke) Adopted

lower

Jan 13, 2021

Vetoed

Motion Special Order vote on veto until 2/8 (Delegate Luedtke) Adopted

lower

May 7, 2020

Vetoed

Vetoed by the Governor (Policy)

executive

Mar 18, 2020

Lower · Passed

Returned Passed

lower

Mar 17, 2020

Upper · Passed

Third Reading Passed

upper

Mar 17, 2020

Upper · Passed

Favorable Adopted Second Reading Passed

upper

Mar 17, 2020

Upper · Passed

Favorable Report by Finance

upper

Mar 15, 2020

Committee

Referred Finance

upper

Mar 15, 2020

Lower · Passed

Third Reading Passed

lower

Mar 14, 2020

Lower · Passed

Favorable with Amendments {

lower

Mar 14, 2020

Lower · Passed

Favorable with Amendments Report by Health and Government Operations

lower

Mar 12, 2020

House Of Delegates · Passed

House of Delegates Vote: pass (66-29-5)

house of delegates

Feb 6, 2020

Committee

First Reading Health and Government Operations

lower

4 primary · 0 co-sponsors